10059- IM-3 IDENTIFICATION OF THERAPEUTIC TARGET ANTIGENS USING PATIENT DERIVED GLIOBLASTOMA AND THEIR APPLICATION TO CAR-T THERAP

Hideki Kuroda, Noriyuki Kijima, Kanji Nakagawa, Koki Murakami, Teturou Tachi, Naoki Hosen, Haruhiko Kishima · 2024

Read 10059- IM-3 IDENTIFICATION OF THERAPEUTIC TARGET ANTIGENS USING PATIENT DERIVED GLIOBLASTOMA AND THEIR APPLICATION TO CAR-T THERAP by Hideki Kuroda, Noriyuki Kijima, Kanji Nakagawa, Koki Murakami, Teturou Tachi, Naoki Hosen, Haruhiko Kishima (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11605651.txt.

Description

Kuroda and six co-authors report a study from twenty twenty-four that hunts for a new target on glioblastoma cells. Glioblastoma is a fast brain tumor, and cell therapy that works in blood cancers has failed here so far. The team grew tumor cells taken from patients and made a large set of antibodies in mice. They kept only the ones that stuck to tumor cells and not to healthy brain cells.

The search found a surface protein called PTGFRN on the tumor cells. The team built immune cells that attack cells with that protein. Those cells killed tumor cells in dishes and shrank tumors in mice. The work names a fresh target for brain tumor therapy.

Catalog record

CREATORHideki Kuroda, Noriyuki Kijima, Kanji Nakagawa, Koki Murakami, Teturou Tachi, Naoki Hosen, Haruhiko Kishima
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE2 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11605651

Browse the full library · About the Tower of Babel